Tech Company Financing Transactions

SPR Therapeutics Funding Round

SPR Therapeutics secured a $85 million Series D funding round on 2/1/2024. Backers included Revelation Partners and Mutual Capital Partners.

Transaction Overview

Company Name
Announced On
2/1/2024
Transaction Type
Debt
Venture Equity
Amount
$85,000,000
Round
Series D
Proceeds Purpose
The company intends to use the funds to capitalize on commercial momentum, customer demand, and market opportunity to expand its sales representation in additional U.S. sales territories. In addition to sales expansion, proceeds will support continued product development.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
22901 Millcreek Blvd. 110
Cleveland, OH 44122
USA
Email Address
Overview
SPR Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. We are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach.
Profile
SPR Therapeutics LinkedIn Company Profile
Social Media
SPR Therapeutics Company Twitter Account
Company News
SPR Therapeutics News
Facebook
SPR Therapeutics on Facebook
YouTube
SPR Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Maria Bennett
  Maria Bennett LinkedIn Profile  Maria Bennett Twitter Account  Maria Bennett News  Maria Bennett on Facebook
Chief Medical Officer
John Chae
  John Chae LinkedIn Profile  John Chae Twitter Account  John Chae News  John Chae on Facebook
Chief Scientific Officer
Warren Grill
  Warren Grill LinkedIn Profile  Warren Grill Twitter Account  Warren Grill News  Warren Grill on Facebook
VP - Marketing
Mark Stultz
  Mark Stultz LinkedIn Profile  Mark Stultz Twitter Account  Mark Stultz News  Mark Stultz on Facebook
VP - R & D
Joseph Boggs
  Joseph Boggs LinkedIn Profile  Joseph Boggs Twitter Account  Joseph Boggs News  Joseph Boggs on Facebook
VP - Sales
David Youngberg
  David Youngberg LinkedIn Profile  David Youngberg Twitter Account  David Youngberg News  David Youngberg on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/1/2024: Izote Biosciences venture capital transaction
Next: 2/1/2024: Harbor venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary